18 December 2020 in Bulletin of Russian State Medical University
The lack of information about the frequency of pharmacogenetic markers in Russia impedes the adoption of personalized treatment algorithms originally developed for West European populations. The aim of this paper was to study the distribution of some clinically significant pharmacogenetic markers across Russia. A total of 45 pharmacogenetic markers were selected from a few population genetic datasets, including ADME, drug target and hemostasis-controlling genes. The total number of donors genotyped for these markers was 2,197. The frequencies of these markers were determined for 50 different populations, comprised of 137 ethnic and subethnic groups. A comprehensive pharmacogenetic atlas was created, i.e. a systematic collection of gene geographic maps of frequency variation for 45 pharmacogenetic DNA markers in Russia and its neighbor states. The maps revealed 3 patterns of geographic variation. Clinal variation (a gradient change in frequency along the East-West axis) is observed in the pharmacogenetic markers that follow the main pattern of variation for North Eurasia (13% of the maps). Uniform distribution singles out a group of markers that occur at average frequency in most Russian regions (27% of the maps). Focal variation is observed in the markers that are specific to a certain group of populations and are absent in other regions (60% of the maps). The atlas reveals that the average frequency of the marker and its frequency in individual populations do not indicate the type of its distribution in Russia: a gene geographic map is needed to uncover the pattern of its variation.
1 November 2023 in Electronic Journal of General Medicine
Purpose: Assessment of public knowledge of chronic kidney disease (CKD) is an essential step in development of CKD prevention and screening programs. Our aim was to estimate the level of public CKD knowledge and its predictors in the former Soviet Union countries using a validated questionnaire. Materials and methods: This cross-sectional survey was conducted in 10 countries using an adapted validated online questionnaire. Descriptive statistics were used to describe participants’ characteristics and assess public CKD knowledge level. A multiple linear regression analysis was performed to identify predictors of CKD knowledge. Results: 2,715 participants satisfied the inclusion criteria. Respondents having higher level of education, living in countries belonging to the lower middle-income countries, having a personal history of diabetes and hypertension, and having a family history of kidney disease showed significantly better CKD knowledge. Conclusions: The level of CKD knowledge among the population of post-Soviet states was found to be low, although some personal characteristics were associated with better CKD knowledge.
1 October 2025 in Science Progress
Background: Direct oral anticoagulants (DOACs) are first-line medications for stroke prevention in non-valvular atrial fibrillation (AF). However, variability in drug response poses risks of hemorrhagic or thromboembolic events. Objectives: Although genetic influences on DOACs safety are increasingly recognized, robust evidence directly linking specific polymorphisms to bleeding risk remains limited. Design: Multi-center observational case–control study including exome-wide association analysis of 196 non-valvular AF patients treated with rivaroxaban or apixaban, comprising 97 with bleeding complications and 99 without. Methods: DOAC plasma concentrations, urinary 6-β-hydroxycortisol and cortisol levels were measured for CYP3A4 phenotyping. Sequencing was performed on the DNBSEQ G-400 platform. Single-nucleotide variant (SNV) associations with bleeding risk were assessed using logistic regression with additive, dominant, and recessive genetic models. Polygenic risk scores (PRSs) were calculated to evaluate cumulative genetic effects. Results: No SNVs reached Bonferroni-corrected significance under any model. PRSs showed weak predictive ability for bleeding with apixaban. For rivaroxaban, regression indicated that ln C ss min /D + 1 index increased with PRS, age, and 6-β-hydroxycortisol/cortisol ratio, but decreased with higher 6-β-hydroxycortisol and coronary heart disease presence. No statistically significant differences were found for the PharmGKB Level 3 variants rs1045642 (rivaroxaban) and rs2231142 (apixaban). Trends toward statistical significance were observed for the rs2472304-G variant in rivaroxaban users, rs6977165-C in apixaban users, and for the CYP3A4*1/*36 diplotype. Conclusion: Residual equilibrium concentration of DOACs, including dose-adjusted, did not independently predict bleeding risk in non-valvular AF patients. Variants rs2472304 and rs6977165 may warrant further investigation as potential contributors to bleeding risk.
2 April 2021 in Journal of Renal Injury Prevention
The mini-review presents modern data on the epidemiology, clinical and morphological aspects of kidney damage in COVID-19. Potential mechanisms of kidney involvement in the clinical picture of the disease may include cytokine damage, cross-organ damage, and systemic effects that determine the treatment strategy. These mechanisms are closely interrelated and are especially important for individuals undergoing extracorporeal therapy and kidney transplants. Autopsy data provide evidence of SARS-CoV-2 virus invasion into kidney tissue with damage to tubular epithelial cells and podocytes, and erythrocyte aggregation in persons with severe COVID-19. By including people with chronic kidney disease in planned COVID-19 research protocols, an evidence base for effective and safe treatments can be generated.
1 June 2018 in Journal Of Hypertension
Endothelial dysfunction plays an important role in development and progression of arterial hypertension. In recent years there was reported that polyphenolic compounds improve the function of endothelium, however, their molecular mechanisms on endothelial cells remain unclarified. Purpose of study was to determine whether polyphenols (quercetin, caffeic acid or resveratrol) are able to improve NO-dependent vasodilation in rat aortic rings. Male Wistar rats were anaesthetized by chloralhydrate over dose and decapitated. Descending thoracic aorta was carefully excised and cut into ring segments 3 mm in length and then transferred into organ baths containing Krebs solution bubbled with mixture of 95% O2 and 5% CO2. Rings were precontracted with 0.3 uM Phenylephine and increasing concentrations of acetylcholine (Ach, 0.001 uM - 30 uM) were cumulatively added to organ bath. At the beginning of each experiment, all rings were pretreated with diclofenac for 30 minutes to prevent the generation of vasoactive prostanoid metabolites. Quercetin, caffeic acid or resveratrol (10 uM) was added to organ baths for 20 minutes before investigation of relaxant responses to ACh. Some rings were incubated in the DMSO (solvent, control). ACh elicited a concentration-dependent relaxation of rat aortic rings. After exposure to quercetin the relaxant responses to all concentrations of ACh were markedly potentiated. There was no significant relaxant response to ACh in caffeic acid and resveratrol groups. Maximum relaxation (E max, %) was increased from 54.6 ± 3.3 in control group to 67.3 ± 3.8 in quercetin group, and 63.4 ± 4.8 and 62.4 ± 5.1 in caffeic acid and resveratrol group, respectively (P < 0.05). Negative logarithm of EC50 (pD2) value in control study was 5.2 ± 0.28. After pretreatment with quercetin, caffeic acid and resveratrol pD2 values were 6.1 ± 0.16, 5.6 ± 0,18 and 5.4 ± 0.32, respectively (P < 0.005 vs. control). Our results demonstrate that quercetin improves endothelial dysfunction due to increased NO-dependent vasodilation. This mechanism could be associated with decrease in the ROS level and related decrease in inactivation of NO, or with activation of eNOS and related increase in NO synthesis in the endothelium. Study was supported by grant from Russian Foundation for Basic Research 15-04-05-211.
1 April 2021 in Kidney International Reports